» Articles » PMID: 30044439

Effect of Long-Term Xanthophyll and Anthocyanin Supplementation on Lutein and Zeaxanthin Serum Concentrations and Macular Pigment Optical Density in Postmenopausal Women

Overview
Journal Nutrients
Date 2018 Jul 26
PMID 30044439
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Xanthophylls (lutein, L; zeaxanthin, Z) and anthocyanins are often included in food supplements to improve ocular health. There are no dietary reference intakes for them. The aim was to assess the effects of L, Z and anthocyanin supplementation on short and long-term lutein status markers (serum concentration and macular pigment optical density (MPOD)). Seventy-two postmenopausal women were randomized into a parallel study of 8 months: Group A-anthocyanines (60 mg/day); Group X-xanthophylls (6 mg L + 2 mg Z/day); Group X+A-anthocyanines (60 mg/day) + xanthophylls (6 mg L + 2 mg Z/day). At the beginning of the study, 4 and 8 month serum L and Z concentrations were determined (HPLC), as well as L, Z and anthocyanine dietary intake and MPOD (heterochromic flicker photometry). Baseline concentrations of L (0.35 ± 0.19 μmol/L), Z (0.11 ± 0.05 μmol/L), L+Z/cholesterol/triglycerides (0.07 ± 0.04 μmol/mmol) increased in Group X (2.8- and 1.6-fold in L and Z concentrations) and in group XA (2- and 1.4-fold in L and Z concentrations). MPOD (baseline: 0.32 ± 0.13 du) was not modified in any of the groups at the end of the study. There were no differences in the dietary intake of L+Z and anthocyanin at any point in time in any group. Supplementation of L and Z at a dietary level provoked an increase in their serum concentration that was not modified by simultaneous supplementation with anthocyanins.

Citing Articles

Natural pigments: innovative extraction technologies and their potential application in health and food industries.

Masyita A, Hardinasinta G, Astuti A, Firdayani F, Mayasari D, Hori A Front Pharmacol. 2025; 15():1507108.

PMID: 39845791 PMC: 11750858. DOI: 10.3389/fphar.2024.1507108.


An Overview on the Effects of Some Carotenoids on Health: Lutein and Zeaxanthin.

Sanlier N, Yildiz E, Ozler E Curr Nutr Rep. 2024; 13(4):828-844.

PMID: 39304612 DOI: 10.1007/s13668-024-00579-z.


The Role of Reactive Oxygen Species in Age-Related Macular Degeneration: A Comprehensive Review of Antioxidant Therapies.

Kulbay M, Wu K, Nirwal G, Belanger P, Tran S Biomedicines. 2024; 12(7).

PMID: 39062152 PMC: 11274723. DOI: 10.3390/biomedicines12071579.


Xanthophyll pigments dietary supplements administration and retinal health in the context of increasing life expectancy trend.

Jurja S, Negreanu-Pirjol T, Vasile M, Hincu M, Coviltir V, Negreanu-Pirjol B Front Nutr. 2023; 10:1226686.

PMID: 37637949 PMC: 10450221. DOI: 10.3389/fnut.2023.1226686.


Antioxidant supplements in age-related macular degeneration: are they actually beneficial?.

Banerjee M, Chawla R, Kumar A Ther Adv Ophthalmol. 2021; 13:25158414211030418.

PMID: 34471798 PMC: 8404659. DOI: 10.1177/25158414211030418.


References
1.
FRIEDEWALD W, Levy R, Fredrickson D . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18(6):499-502. View

2.
Hidalgo M, Martin-Santamaria S, Recio I, Sanchez-Moreno C, de Pascual-Teresa B, Rimbach G . Potential anti-inflammatory, anti-adhesive, anti/estrogenic, and angiotensin-converting enzyme inhibitory activities of anthocyanins and their gut metabolites. Genes Nutr. 2012; 7(2):295-306. PMC: 3316741. DOI: 10.1007/s12263-011-0263-5. View

3.
Gorusupudi A, Nelson K, Bernstein P . The Age-Related Eye Disease 2 Study: Micronutrients in the Treatment of Macular Degeneration. Adv Nutr. 2017; 8(1):40-53. PMC: 5227975. DOI: 10.3945/an.116.013177. View

4.
Mares J, LaRowe T, Snodderly D, Moeller S, Gruber M, Klein M . Predictors of optical density of lutein and zeaxanthin in retinas of older women in the Carotenoids in Age-Related Eye Disease Study, an ancillary study of the Women's Health Initiative. Am J Clin Nutr. 2006; 84(5):1107-22. DOI: 10.1093/ajcn/84.5.1107. View

5.
. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. 2013; 309(19):2005-15. DOI: 10.1001/jama.2013.4997. View